Rhythm Pharmaceuticals gains on report of additional bidder

Seeking Alpha · Joshua Fineman · 2026-11-06 16:06 UTC

Rhythm Pharmaceuticals jumps on a reported second bidder after AstraZeneca’s near-$10B offer.

Rhythm Pharmaceuticals (RYTM) rose 4.2% amid a report of a second bidder for the biotech company.

One of the world's largest pharmaceutical companies is speculated to have made a counteroffer, according to traders, who cited a Betaville "uncooked" alert that was circulating on Friday.

Read the full story at Seeking Alpha · All coverage of this story